Around 400 million people are still vulnerable to COVID-19 infection as a nationwide survey found two-thirds of the country's population aged above six to have SARS-CoV-2 antibodies, the government said on Tuesday as it stressed there is no room for complacency in the fight against the pandemic.
Findings of the ICMR's 4th national Covid sero survey show there is a ray of hope, but there is no room for complacency and Covid-appropriate behaviour has to be followed, the government said.
The Indian Council of Medical Research (ICMR) conducted the latest survey in June-July.
Addressing a press conference, a senior official said two-thirds or 67.6 per cent of India's population aged above 6 years were found to have SARS-CoV-2 antibodies in the latest national sero survey.
A third of the population did not have SARS-CoV-2 antibodies, which means about 400 million people are still vulnerable to COVID-19 infection, the official said.
According to the government, 85 per cent of the surveyed healthcare workers had antibodies against SARS-CoV-2 and one-tenth of HCWs were still unvaccinated.
The survey covered 28,975 general population and 7,252 healthcare workers.
Stressing observance of COVID-19-appropriate behaviour, the government said social, religious and political congregations should be avoided and non-essential travels should be discouraged.
"Travel only if fully vaccinated," it said.
The ICMR also suggested that it would be wise to consider reopening primary schools first as children can handle viral infection much better.
"Children can handle viral infection much better as they have lower number of ace receptors. So once the decision is taken and all the staff vaccinated, it would be wise to open primary schools first," it said.
India recorded 30,093 new coronavirus infections, the lowest in 125 days, taking the total tally of COVID-19 cases to 3,11,74,322, according to the Union Health Ministry data updated on Tuesday.
The death toll climbed to 4,14,482 with 374 daily fatalities, the lowest in 111 days, while the active cases have declined to 4,06,130, the lowest in 117 days.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)